IPHA   $2.04  2.51% Market Closed

Innate Pharma SA
Total Cash 91.80M
totalCashPerShare 1.134
EBITDA -35.96M
Total Debt 35.50M
quickRatio 2.763
currentRatio 2.919
Total Revenue 33.79M
debtToEquity 123.291
Revenue/Share 0.419
ROA -0.13758
ROE -0.78587997
grossProfits
freeCashflow 13.06M
operatingCashflow -18.06M
earningsGrowth
revenueGrowth -0.693
grossMargins -0.58769
ebitdaMargins -1.06425
operatingMargins -2.13147
profitMargins -1.00781
enterpriseValue 108.03M
forwardPE
floatShares 31.56M
sharesOutstanding 80.95M
sharesShort 71.84K
sharesShortPriorMonth 65.13K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.0
heldPercentInstitutions 0.00%
Short Ratio help_outline 8.71%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 0.356
Price To Book help_outline 5.90
earningsQuarterlyGrowth
netIncomeToCommon -34.05M
trailingEps -0.46%
forwardEps 0.45%
enterpriseToEbitda -3.00
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 10
lastUpdated Oct. 16, 2024, 11:56 p.m.